EN | RU
EN | RU

Help Support

Back

Hormonal intrauterine contraception and high-intensity focused Ultrasound improves therapeutic effect in dysmenorrhea

Hormonal intrauterine contraception and high-intensity focused Ultrasound improves therapeutic effect in dysmenorrhea Hormonal intrauterine contraception and high-intensity focused Ultrasound improves therapeutic effect in dysmenorrhea
Hormonal intrauterine contraception and high-intensity focused Ultrasound improves therapeutic effect in dysmenorrhea Hormonal intrauterine contraception and high-intensity focused Ultrasound improves therapeutic effect in dysmenorrhea

What's new?

Gynecologists can consider a combination of High-intensity focused ultrasound and levonorgestrel-releasing intrauterine system for dysmenorrhea.

Although High-intensity focused ultrasound (HIFU) had been known to provide short term symptom improvement of dysmenorrhea, but, a combination of HIFU and levonorgestrel-releasing intrauterine system (LNG-IUS) can be an effective long-term therapy for the same, a study published in Journal of Computer assisted Tomography ascertained.

This retrospective analysis was performed on 243 patients with acute adenomyosis to examine the effectiveness of HIFU plus gonadotropin-releasing hormone agonist or LNG-IUS in dysmenorrhea treatment. These patients were divided into:

  • H group: PH group: Patients subjected to HIFU alone,
  • H-G group: Patients subjected to HIFU and gonadotropin-releasing hormone agonist, and
  • H-L group: Patients subjected HIFU and LNG-IUS

Following the therapy, a comparison of clinical results was done at 3 months, 6 months, and 1 year.

A noteworthy difference in effective rates of dysmenorrhea relief after 12 months, but not 3 or 6 months was observed:


Also, H group had substantial differences in dysmenorrhea efficacy amongst patients of various ages or ablation rates at 1 year after the therapy.

Source:

Journal of Computer assisted Tomography

Article:

High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis

Authors:

Yaping Xu et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: